Recent News

SABCS 2019: Tucatinib-Based Therapy for HER2-Positive Metastatic Breast Cancer

FDA Approves Companion Diagnostic for Alpelisib in PIK3CA-Mutated Metastatic Breast Cancer

Potential Role of E-cadherin in Breast Cancer Metastasis

How Does HIV Infection Affect Survival in Patients With Breast Cancer?

Novel Approach to Targeting Metastatic Breast Cancer Through Sonoporation

Updated USPSTF Recommendation on Medication Use to Reduce Breast Cancer Risk

NCRI Conference: Ongoing Study of Blood Test for Early Detection of Breast Cancer

KEYNOTE-119 Trial of Pembrolizumab Versus Chemotherapy for Triple-Negative Breast Cancer

Pembrolizumab Plus Chemotherapy in Triple-Negative Breast Cancer

FDA Grants Priority Review for Trastuzumab Deruxtecan in Metastatic Breast Cancer

FDA Recommends Warnings on Labeling for Breast Implants

ESMO 2019: Adding Veliparib to Chemotherapy for BRCA-Mutated Breast Cancer

ASCO Breakthrough 2019: Genetic Predictors of Breast Cancer Recurrence After Radiation Therapy

ESMO 2019: Survival Benefit Reported With CDK4/6 Inhibitor in Advanced Breast Cancer

Higher Exposure to Toxic Metals May Equal Higher Breast Cancer Risk

Can Artificial Intelligence Improve Accuracy of Digital Breast Tomosynthesis?

ESMO 2019: Improved Overall Survival With Abemaciclib/Fulvestrant in Advanced Breast Cancer

Quality Care 2019: Web-Based Survey of Patient Engagement Among Breast Cancer Survivors

Quality Care 2019: Chemotherapy Decisions of Older Women With Early-Stage Breast Cancer

Quality Care 2019: Pilot Program Focuses on Improving Breast Cancer Staging Data Entries

ASTRO 2019: Postmastectomy Radiation Therapy for HER2-Positive Breast Cancer

FDA Issues Warning About Lung Inflammation and Use of CDK4/6 Inhibitors

USPSTF Recommendation Updates for Women With BRCA-Related Cancer

Quality Care 2019: Impact of Breast Cancer on Key Support Person’s Employment

Is Red Meat Consumption Linked to Breast Cancer Risk?

Two-Drug Combination Targets Resistance in Cancer

FDA Draft Guidance Encourages Inclusion of Male Patients in Breast Cancer Clinical Trials

Comparing First-Line Treatments in Triple-Negative Breast Cancer

Real-World Data on Palbociclib Plus Endocrine Therapy in Men With Advanced Breast Cancer

IMpassion130 Trial: Atezolizumab Plus Nab-paclitaxel in Advanced Triple-Negative Breast Cancer

Is Soy Intake Related to Bone Fractures for Breast Cancer Survivors?

FDA Requests Manufacturer Recall of Certain Textured Breast Implants

Does Eribulin Mesylate Plus Pembrolizumab Improve Outcomes in Metastatic Breast Cancer?

Communicating With Older Patients About the Need for Breast Cancer Screening

Updated ASCO Clinical Practice Guideline Integrates TAILORx Trial Results in Breast Cancer

NALA Trial: Neratinib Versus Lapatinib Combination Therapy for Metastatic Breast Cancer

De-escalation of Bone-Targeting Agents for Bone Metastases From Breast Cancer

SOPHIA Trial: Adding Margetuximab or Trastuzumab to Chemotherapy in Breast Cancer

Comparing Radiation Regimens in Early-Stage Breast Cancer

Does Environmental Quality Impact the Odds of Developing Aggressive Breast Cancer?

Racial Differences in Risk of Aggressive Breast Cancer After Ductal Carcinoma in Situ

ASCO 2019: Novel Targeted Therapy Active in Metastatic Breast Cancer

ASCO 2019: Final Results of KRISTINE Trial of Neoadjuvant Regimens in HER2-Positive Breast Cancer